Serotonin-related gene pathways associated with undifferentiated somatoform disorder

Psychiatry Research

Volumn 189, Issue 2, 2011, Pages 246-250

  Koh, Kyung Bong ^a   Choi, Eun Hee ^a   Lee, Young joon ^a   Han, Mooyoung ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Epigenetic factors; Specific serotonin related gene pathways; Undifferentiated somatoform disorder

Indexed keywords

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; CULTURAL FACTOR; DEPRESSION; DISEASE ASSOCIATION; EPIGENETICS; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RECEPTOR GENE; RISK FACTOR; SCORING SYSTEM; SEROTONIN 2A RECEPTOR GENE; SEROTONIN TRANSPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL PSYCHOLOGY; SOMATOFORM DISORDER; SYMPTOM CHECKLIST 90; TRYPTOPHAN HYDROXYLASE 1 GENE;

ADULT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOLOGICAL TESTS; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SIGNAL TRANSDUCTION; SOMATOFORM DISORDERS; TRYPTOPHAN HYDROXYLASE; YOUNG ADULT;

EID: 80052787868     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.04.002     Document Type: Article

References (46)

1. Anguelova M., Benkelfat C., Turecki G. A systemic review of association studies investigating gene coding for serotonin receptors and the serotonin transporter, II: suicidal behavior. Molecular Psychiatry 2003, 8:646-653.
2. Anguelova M., Benkelfat C., Turecki G. A systemic review of association studies investigating gene coding for serotonin receptors and the serotonin transporter, I: affective disorders. Molecular Psychiatry 2003, 8:574-591.
3. Belous A.R., Ramamoorthy S., Blakely R.D., Factor M.I., Dupin A.M., Katasonov A.B., Lozier R.H., Beniashvili A.G. The state of the serotonin transporter protein in the platelets of patients with somatoform disorders. Neuroscience and Behavioral Physiology 2001, 31:185-189.
4. Chang D.F., Myers H.F., Yeung A., Zhang Y., Zhao J., Yu S. Shenjing shuairuo and the DSM-IV: diagnosis, distress, and disability in a Chinese primary care setting. Transcultural Psychiatry 2005, 42:204-218.
5. Choi M.J., Lee H.J., Lee H.J., Ham B.J., Cha J.H., Ryu S.H., Lee M.S. Association between major depressive disorder and the -1438A/G polymorphism of the serotonin 2A receptor gene. Neuropsychobiology 2004, 49:38-41.
6. De Waal M.W., Arnold I.A., Eekhof J.A., van Hemert A.M. Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders. The British Journal of Psychiatry 2004, 184:470-476.
7. Derogatis L.R., Rickels K., Rock A.F. The SCL-90 and MMPI: a step in the validation of a new report scale. The British Journal of Psychiatry 1976, 128:280-289.
8. Du L., Bakish D., Lapierre Y.D., Ravindran A.V., Hrdina P.D. Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2000, 96:56-60.
9. Ebstein R.P., Gritsenko I., Nemanov L., Frisch A., Osher Y., Belmaker R.H. No association between the serotonin transporter gene regulatory region polymorphism and the tridimensional personality questionnaire (TPQ) temperament of harm avoidance. Molecular Psychiatry 1997, 2:224-226.
10. Eley T.C., Sugden K., Corsico A., Gregory A.M., Sham P., McGuffin P., Plomin R., Graig I.W. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Molecular Psychiatry 2004, 9:908-916.
11. Enoch M.A., Goldman D., Barnett R., Sher L., Mazzanti C.M., Rosenthal N.E. Association between seasonal affective disorder and the 5-HT2A promoter polymorphism, -1438G/A. Molecular Psychiatry 1999, 4:89-92.
12. First M.B., Spitzer R.L., Gibbon M., William J.B.W. Structured Clinical Interview Schedule for DSM-IV Axis 1 Disorders, Research Version, Patient/Non-patient Edition. Biometircs Research 1996, New York State Psychiatric Institute, New York.
13. Guggenheim F.G. Somatoform disorder. Comprehensive Textbook of Psychiatry 2000, 1504-1532. Lippincott Williams & Wilkins, Baltimore, Md. 7th ed. B.J. Sadock, V.A. Sadock (Eds.).
14. Hahn O., Hong J. Korean Version of Structured Clinical Interview Schedule for DSM-IV Axis 1 Disorders, Research Version 2000, Hana Medical Co., Seoul.
15. Hahn O., Ahn J., Song S., Cho M., Kim J., Bae J., Cho S., Jeong B.S., Suh D., Hahm B., Lee D., Park J., Hong J. Development of Korean version of structured clinical interview schedule for DSM-IV axis 1 disorders: interrater reliability. Journal of Korean Neuropsychiatric Association 2000, 39:362-372.
16. Hamilton M.A. A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 1960, 23:56-62.
17. Heils A., Teufel A., Petri S., Stöber G., Riederer P., Bengel D., Lesch K.P. Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry 1996, 66:2621-2624.
18. Hennings A., Zill P., Rief W. Serotonin transporter gene promoter polymorphism and somatoform symptoms. The Journal of Clinical Psychiatry 2009, 70:1536-1539.
19. Katon W., Kleinman A., Rosen G. Depression and somatization: a review, part 1. The American Journal of Medicine 1982, 72:127-135.
20. Kellner R., Hernandez J., Pathak D. Self-rated anger, somatization and depression. Psychotherapy and Psychosomatics 1992, 57:102-107.
21. Kim K.I., Kim J.H., Won H.T. Korean Manual of Symptom Checklist-90-Revision 1984, Chung Ang Aptitude Publishing Co., Seoul.
22. Koh K.B. Stress and Psychosomatic Medicine 2002, 231-249. Ilchokak, Seoul, Korea.
23. Koh K.B., Kim D.K., Kim S.Y., Park J.K. The relation between anger expression, depression, and somatic symptoms in depressive disorders and somatoform disorders. The Journal of Clinical Psychiatry 2005, 66:485-491.
24. Koh K.B., Kim D.K., Kim S.Y., Park J.K., Han M.Y. The relation between anger mangagement style, mood, and somatic symptoms in anxiety disorders and somatoform disorders. Psychiatry Research 2008, 160:372-379.
25. Lasky-Su J.A., Faraone S.V., Glatt S.J., Tsuang M.T. Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2005, 133B:110-115.
26. LeiKeiknes K.A., Finset A., Mount T., Sandanger I. Current somatoform disorders in Norway: prevalence, risk factors and comorbidity with anxiety, depression and musculoskeltal disorders. Social Psychiatry and Psychiatric Epidemiology 2007, 42:698-710.
27. Lesch K.-P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Müller C.R., Hamer D.H., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
28. Lesse S. Masked depression - the ubiquitous but unappreciated syndrome. Psychiatry Journal of University of Ottawa 1980, 5:268-273.
29. Li D., He L. Meta-analysis supports association between serotonin transporter (5HTT) and suicidal behavior. Molecular Psychiatry 2007, 12:47-54.
30. Lin K.M. Hwa-byung: a Korean culture-bound syndrome?. The American Journal of Psychiatry 1983, 140:105-107.
31. Lin P.Y., Tsai G. Association between serotonin transporter gene promoter polymorphism and suicide: results of a meta-analysis. Biological Psychiatry 2004, 55:1023-1030.
32. Mann J.J. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 1999, 21:99S-105S.
33. Mezzich J.E., Lin K., Hughes C.C. Acute and transient psychotic disorders and culture bound syndromes. Comprehensive Textbook of Psychiatry 2000, 1264-1276. Lippincott Williams & Wilkins, Baltimore, Md. 7th ed. B.J. Sadock, V.A. Sadock (Eds.).
34. Min S.K. A study of the concept of hwabyung. Journal of Korean Neuropsychiatric Association 1989, 28:604-616.
35. Min S.K., Lee M.H., Shin J.H. A diagnostic study on hwabyung. Journal of Korean Medical Association 1986, 29:653-661.
36. Oquendo M.A., Mann J.J. Neuroimaging findings in major depression, suicidal behavior and aggression. Clinical Neuroscience Research 2001, 1:377-380.
37. Owens M.J., Nemeroff C.B. Role of serotonin in pathophysiology of depression: focus on the serotonin transporter. Clinical Chemistry 1994, 40:288-295.
38. Peters E.J., Slager S.L., McGrath P.J., Knowles J.A., Hamilton S.P. Investigation of serotonin-related genes in antidepressant response. Molecular Psychiatry 2004, 9:879-889.
39. Pickar D., Rubinow K. Pharmacogenomics of psychiatric disorders. Trends in Pharmacological Sciences 2001, 22:75-83.
40. Rosenthal N.E., Mazzanti C.M., Barnett R.L., Hardin T.A., Turner H., Lam G.K., Ozaki N., Goldman D. Role of serotonin transporter promoter repeat length polymorphism (5-HTTLPR) in seasonality and seasonal affective disorder. Molecular Psychiatry 1998, 3:175-177.
41. Rujescu D., Giegling I., Bondy B., Gietl A., Zill P., Moller H.-J. Association of anger-related traits with SNPs in the TPH gene. Molecular Psychiatry 2002, 7:1023-1029.
42. Sadock B.J., Sadock V.A. Synopsis of Psychiatry 2003, 643-660. Lippincott Williams & Wilkins, Philadelphia. 9th ed.
43. Serretti A., Zanardi R., Cusin C., Rossini D., Lorenzi C., Smeraldi E. Tryptophan hydroxylalse gene associated with paroxetine antidepressant activity. European Neuropsychopharmacology 2001, 11:375-380.
44. Serretti A., Zanardi R., Rossini D., Cusin C., Lilli R., Smeraldi E. Influence of tryptophan hydroxylalse and serotonin transporter genes on fluvoxamine antidepressant activity. Molecular Psychiatry 2001, 6:586-592.
45. Zill P., Baghai T.C., Zwanzger P., Schule C., Eser D., Rupprecht R., Moller H.J., Bondy B., Ackenheil M. SNP and halotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Molecular Psychiatry 2004, 9:1030-1036.
46. Zill P., Buttner A., Eisenmenger W., Bondy B., Ackenheil M. Regional mRNA expression of a second tryptophan hydroxylase isoform in postmortem tissue samples of two human brains. European Neuropsychopharmacology 2004, 14:282-284.